Hospitals and Related Institutions; hormone therapies and puberty-blocking medications for certain purposes to minors; prohibit prescribing or administering
SB 30 would prohibit, with limited exceptions, the use of certain medical treatments on minors when those treatments are provided for the purpose of affirming a gender identity inconsistent with the minor’s sex as defined in the bill. The measure targets sex reassignment surgeries, hormone replacement therapies, and puberty-blocking medications, and it defines those terms broadly in both the hospital-regulation and medical-board sections of Georgia law. The bill also defines “sex” in biological terms and specifies that the prohibited treatments are those intended to alter a minor’s appearance or perception of sex.
The bill creates narrow pathways for puberty-blocking medication to be used, but only if multiple conditions are met, including diagnoses by two independent behavioral health professionals, evaluation by a board-certified physician, written informed consent from parents or guardians, annual reporting to the Georgia Composite Medical Board, and quarterly psychological counseling. It also preserves exceptions for certain medically necessary treatments unrelated to gender dysphoria, for individuals with disorders of sex development, for partial androgen insensitivity syndrome, and for some minors already receiving treatment before specified dates. In addition, the bill authorizes administrative sanctions against institutions and disciplinary action against physicians, and it creates a private right of action for parents or guardians to sue institutions or physicians for violations within two years.
In terms of state law, SB 30 would amend both the hospital licensing framework in Title 31 and the Georgia Composite Medical Board’s authority in Title 43. It would add enforcement mechanisms through agency sanctions and professional discipline, while also exposing providers and institutions to civil liability in certain cases. The bill would therefore affect hospitals, licensed physicians, the Georgia Composite Medical Board, minors seeking gender-affirming care, and parents or guardians making medical decisions on behalf of minors.
The available vote history suggests the bill had meaningful support in the Senate, passing 34-19 after an amendment failed 20-34. No committee transcript is available here, so the broader discussion record is limited, but the structure of the bill indicates a strong policy preference for restricting gender-affirming medical care for minors while preserving limited exceptions and oversight. The overall sentiment reflected in the bill text and vote outcome is supportive among proponents of restriction and likely opposed by advocates of gender-affirming care, though no direct committee debate is provided.
The main points of contention are the scope of the prohibition, the bill’s definition of sex and gender dysphoria-related treatment, and whether the exceptions are sufficiently broad or too restrictive. Supporters are likely to emphasize child protection, informed consent, and medical oversight, while opponents are likely to object to the ban on gender-affirming care for minors, the involvement of courts in parental disputes, and the potential for civil liability and professional sanctions against providers.
SB 30 would substantially revise Georgia law governing hospitals and physicians by prohibiting specified gender-affirming surgeries, hormone therapies, and puberty-blocking medications for minors, except under tightly defined conditions. It would amend both hospital regulation statutes and the Georgia Composite Medical Board provisions, creating new compliance duties, reporting requirements, enforcement authority, and a private civil cause of action for parents or guardians. The bill would directly affect medical providers, hospitals, minors receiving gender-dysphoria-related care, and state regulators responsible for licensing and discipline.
The bill appears to have had favorable support among Senate majority votes, as shown by final passage on a 34-19 vote, while an amendment failed. With no committee transcript available, there is no detailed record of debate, but the vote pattern suggests the measure was politically supported by a majority and contested by a substantial minority. Overall, the bill’s tone and structure indicate a restrictive approach to gender-affirming care for minors, which is likely to have been welcomed by supporters of such limits and opposed by advocates for access to that care.
The central controversy is whether Georgia should prohibit gender-affirming medical treatment for minors, especially puberty blockers and hormone therapy, and under what circumstances exceptions should exist. Supporters are likely to argue the bill protects minors and requires stronger medical and parental safeguards, while opponents are likely to argue it interferes with medically appropriate care, burdens families and physicians, and uses broad definitions that could sweep in legitimate treatment. Additional contention surrounds the bill’s civil liability provisions, administrative sanctions, and the requirement that courts resolve parental disagreements over treatment.